Filing Details

Accession Number:
0000902664-22-001443
Form Type:
13G Filing
Publication Date:
2022-02-09 19:00:00
Filed By:
Senator Investment Group
Company:
Ginkgo Bioworks Holdings Inc.
Filing Date:
2022-02-10
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
SENATOR INVESTMENT GROUP 0 76,595,199 0 76,595,199 76,595,199 5.8%
DOUGLAS SILVERMAN 0 76,595,199 0 76,595,199 76,595,199 5.8%
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
 
 

Ginkgo Bioworks Holdings, Inc.

(Name of Issuer)
 

Class A Common Stock, par value $0.0001 per share

(Title of Class of Securities)
 

37611X100

(CUSIP Number)
 

December 31, 2021

(Date of Event Which Requires Filing of This Statement)
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨ Rule 13d-1(b)
ý Rule 13d-1(c)
¨ Rule 13d-1(d)
 
(Page 1 of 7 Pages)

 

______________________________

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No. 37611X10013G/APage 2 of 7 Pages

 

1

NAME OF REPORTING PERSON

SENATOR INVESTMENT GROUP LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

DELAWARE

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

76,595,199

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

76,595,199

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

76,595,199

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.8%

12

TYPE OF REPORTING PERSON

IA, PN

         

 

CUSIP No. 37611X10013G/APage 3 of 7 Pages

 

 

1

NAME OF REPORTING PERSON

DOUGLAS SILVERMAN

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

UNITED STATES

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

76,595,199

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

76,595,199

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

76,595,199

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.8%

12

TYPE OF REPORTING PERSON

IN

         

 

 

CUSIP No. 37611X10013G/APage 4 of 7 Pages

 

 

Item 1(a). NAME OF ISSUER
   
  Ginkgo Bioworks Holdings, Inc. (the “Issuer”)

 

Item 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
   
 

27 Drydock Avenue

8th Floor

Boston , MA 02210

 

Item 2 (a). NAME OF PERSON FILING
   
  Senator Investment Group LP (“Senator Investment Group”) serves as investment manager to various investment funds (collectively, the “Funds”), and as such, has investment discretion with respect to the Funds. Douglas Silverman (“Mr. Silverman,” together with Senator Investment Group, the “Reporting Persons”) has control of a Delaware limited liability company that may be deemed to control Senator Investment Group.
   
  The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock (as defined below) reported herein.

 

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
   
  The principal office of each of the Reporting Persons is:
   
  c/o Senator Investment Group LP
  510 Madison Avenue
  28th Floor
  New York, NY 10022

 

Item 2(c). CITIZENSHIP
   
  Senator Investment Group LP is a Delaware limited partnership. Mr. Silverman is a United States citizen.

 

Item 2(d). TITLE OF CLASS OF SECURITIES
   
  Class A common stock, par value $0.0001 per share

 

Item 2(e). CUSIP NUMBER
  37611X100
   

 

 

CUSIP No. 37611X10013G/APage 5 of 7 Pages

 

 

Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act;
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act;
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act;
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940;
  (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
  (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
  (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
  (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
  (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

 

  If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please
  specify the type of institution:    

 

Item 4. OWNERSHIP

 

  Senator Investment Group, LP

 

  (a) Amount of beneficially owned: 76,595,199
     
  (b) Percent of class: 5.8%. The percentages set forth in this Schedule 13G/A are calculated based upon the 1,310,783,159 shares of Common Stock issued and outstanding as of November 8, 2021, as reported in the Issuer’s Prospectus filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on December 10, 2021.
     
  (c) Number of shares as to which such person has:
     
    (i) Sole power to vote or to direct the vote:  0
       
    (ii) Shared power to vote or to direct the vote:  76,595,199

 

CUSIP No. 37611X10013G/APage 6 of 7 Pages

 

 

    (iii) Sole power to dispose or to direct the disposition of:  0
       
    (iv) Shared power to dispose or to direct the disposition of:  76,595,199

 

  Mr. Silverman

 

  (a) Amount of beneficially owned: 76,595,199
     
  (b) Percent of class: 5.8%
     
  (c) Number of shares as to which such person has:
     
    (i) Sole power to vote or to direct the vote:  0
       
    (ii) Shared power to vote or to direct the vote: 76,595,199
       
    (iii) Sole power to dispose or to direct the disposition of:  0
       
    (iv) Shared power to dispose or to direct the disposition of: 76,595,199

 

Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
   
  Not applicable.

 

Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
   
  The partners and shareholders of the Funds have the right to participate in the receipt of dividends from, or proceeds from the sale of, the securities reported herein held by the Funds in accordance with their respective ownership interests in the Funds.

 

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON
   
  Not applicable.

 

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
   
  Not applicable.

 

Item 9. NOTICE OF DISSOLUTION OF GROUP
   
  Not applicable.

 

Item 10. CERTIFICATION
   
  By signing below each of the Reporting Persons certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

 

 

CUSIP No. 37611X10013G/APage 7 of 7 Pages

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

DATE: as of February 10, 2022

 

  SENATOR INVESTMENT GROUP LP
   
  /s/ Evan Gartenlaub
  Name: Evan Gartenlaub
  Title: General Counsel

 

  /s/ Evan Gartenlaub as Attorney-in-Fact*
  DOUGLAS SILVERMAN

 

  

 

* Pursuant to a Power of Attorney attached to the Schedule 13G filed by the Reporting Persons on April 24, 2013.